Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Comparative efficacy and safety of monoclonal antibodies and aspirin desensitization for chronic rhinosinusitis with nasal polyposis: A systematic review and network meta-analysis
Paul Oykhman, Fernando Aleman Paramo, Jean Bousquet, et al.
Journal of Allergy and Clinical Immunology (2021) Vol. 149, Iss. 4, pp. 1286-1295
Open Access | Times Cited: 160

Showing 1-25 of 160 citing articles:

Atopic dermatitis (eczema) guidelines: 2023 American Academy of Allergy, Asthma and Immunology/American College of Allergy, Asthma and Immunology Joint Task Force on Practice Parameters GRADE– and Institute of Medicine–based recommendations
Derek K. Chu, Lynda C. Schneider, Rachel Netahe Asiniwasis, et al.
Annals of Allergy Asthma & Immunology (2023) Vol. 132, Iss. 3, pp. 274-312
Open Access | Times Cited: 98
Type 2 chronic inflammatory diseases: targets, therapies and unmet needs
Pavel Kolkhir, Cezmi A. Akdiş, Mübeccel Akdiş, et al.
Nature Reviews Drug Discovery (2023) Vol. 22, Iss. 9, pp. 743-767
Closed Access | Times Cited: 67
Systemic treatments for atopic dermatitis (eczema): Systematic review and network meta-analysis of randomized trials
Alexandro Chu, Melanie Wong, Daniel Rayner, et al.
Journal of Allergy and Clinical Immunology (2023) Vol. 152, Iss. 6, pp. 1470-1492
Open Access | Times Cited: 58
A guide and pragmatic considerations for applying GRADE to network meta-analysis
Ariel Izcovich, Derek K. Chu, Reem A. Mustafa, et al.
BMJ (2023), pp. e074495-e074495
Open Access | Times Cited: 56
Topical treatments for atopic dermatitis (eczema): Systematic review and network meta-analysis of randomized trials
Derek K. Chu, Alexandro Chu, Daniel Rayner, et al.
Journal of Allergy and Clinical Immunology (2023) Vol. 152, Iss. 6, pp. 1493-1519
Closed Access | Times Cited: 42
Eosinophilic Asthma: Pathophysiology and Therapeutic Horizons
Musaddique Hussain, Gang Liu
Cells (2024) Vol. 13, Iss. 5, pp. 384-384
Open Access | Times Cited: 30
The interleukin-4/interleukin-13 pathway in type 2 inflammation in chronic rhinosinusitis with nasal polyps
Claus Bachert, Alexandra Hicks, Simon Gane, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 16
Chronic Rhinosinusitis with Nasal Polyps and Biologics: A Call for Better Data Standardisation and Presentation in Clinical Studies
Harsha H. Kariyawasam, Dean Langan, Joanne Rimmer
Therapeutics and Clinical Risk Management (2025) Vol. Volume 21, pp. 27-34
Open Access | Times Cited: 2
Comparison of Different Biologics for Treating Chronic Rhinosinusitis With Nasal Polyps: A Network Analysis
Shiru Cai, Shenglong Xu, Hongfei Lou, et al.
The Journal of Allergy and Clinical Immunology In Practice (2022) Vol. 10, Iss. 7, pp. 1876-1886.e7
Closed Access | Times Cited: 60
Comparative efficacy of mepolizumab, benralizumab, and dupilumab in eosinophilic asthma: A Bayesian network meta-analysis
Ayobami Akenroye, Grace Lassiter, John W. Jackson, et al.
Journal of Allergy and Clinical Immunology (2022) Vol. 150, Iss. 5, pp. 1097-1105.e12
Open Access | Times Cited: 51
Targeting Downstream Type 2 Cytokines or Upstream Epithelial Alarmins for Severe Asthma
Rory Chan, Kirsten Stewart, Rasads Misirovs, et al.
The Journal of Allergy and Clinical Immunology In Practice (2022) Vol. 10, Iss. 6, pp. 1497-1505
Open Access | Times Cited: 49
Two‐year results of tapered dupilumab for CRSwNP demonstrates enduring efficacy established in the first 6 months
Rik Johannes Leonardus van der Lans, Josje Janna Otten, Gwijde Flavius Jacobus Petrus Maria Adriaensen, et al.
Allergy (2023) Vol. 78, Iss. 10, pp. 2684-2697
Open Access | Times Cited: 39
The Joint Task Force on Practice Parameters GRADE guidelines for the medical management of chronic rhinosinusitis with nasal polyposis
Matthew A. Rank, Derek K. Chu, Antonio Bognanni, et al.
Journal of Allergy and Clinical Immunology (2022) Vol. 151, Iss. 2, pp. 386-398
Open Access | Times Cited: 38
A real-life comparison of pulmonary and nasal outcomes in patients with severe asthma and nasal polyposis treated with T2-biologics
Ulrike Förster‐Ruhrmann, Dafni Stergioudi, Agnieszka J. Szczepek, et al.
World Allergy Organization Journal (2023) Vol. 16, Iss. 2, pp. 100746-100746
Open Access | Times Cited: 28
Biologic treatment for severe chronic rhinosinusitis with nasal polyps: a systematic review and meta-analysis
Harsha H. Kariyawasam, Deepak P. Chandrasekharan, T Jacques, et al.
Rhinology Journal (2023) Vol. 61, Iss. 2, pp. 98-107
Open Access | Times Cited: 26
Treatable Traits in Asthma: The Importance of Extrapulmonary Traits—GERD, CRSwNP, Atopic Dermatitis, and Depression/Anxiety
Vanessa M. McDonald, Yuto Hamada, Àlvar Agustí, et al.
The Journal of Allergy and Clinical Immunology In Practice (2024) Vol. 12, Iss. 4, pp. 824-837
Closed Access | Times Cited: 13
Switching of biological therapy to dupilumab in comorbid patients with severe asthma and CRSwNP
Cecilia Rosso, Eugenio De Corso, Valerio Conti, et al.
European Archives of Oto-Rhino-Laryngology (2024) Vol. 281, Iss. 6, pp. 3017-3023
Open Access | Times Cited: 12
In Reference to Clinical Effects and Response Time of Biological Drugs in Chronic Rhinosinusitis with Nasal Polyps Patients: Real‐Life Experience
Pietro Orlando, Oreste Gallo
The Laryngoscope (2025)
Closed Access | Times Cited: 1
Effect of Dupilumab in CRSwNP Sinonasal Outcomes from Real Life Studies: A Systematic Review with Meta-analysis
Miguel Rodriguez-Iglesias, Christian Calvo‐Henríquez, Daniel Martín-Jiménez, et al.
Current Allergy and Asthma Reports (2025) Vol. 25, Iss. 1
Open Access | Times Cited: 1
Clinical Evidence of the Use of Mepolizumab in the Treatment of Chronic Rhinosinusitis with Nasal Polyps: A Prospective Observational Study
Antonio Moffa, Francesco Iafrati, Lucrezia Giorgi, et al.
Healthcare (2025) Vol. 13, Iss. 4, pp. 419-419
Open Access | Times Cited: 1
Efficacy and Safety of Biologics for Chronic Rhinosinusitis With Nasal Polyps: A Meta‐Analysis of Real‐World Evidence
Shiru Cai, Shenglong Xu, Yan Zhao, et al.
Allergy (2025)
Open Access | Times Cited: 1
Chinese Position Paper on Biologic Therapy for Chronic Rhinosinusitis With Nasal Polyps
Mu Xian, Bing Yan, Xicheng Song, et al.
Allergy (2025)
Open Access | Times Cited: 1
Translating Evidence to Optimize Patient Care Using GRADE
Derek K. Chu, David B.K. Golden, Gordon Guyatt
The Journal of Allergy and Clinical Immunology In Practice (2021) Vol. 9, Iss. 12, pp. 4221-4230
Closed Access | Times Cited: 54
Real-world-effectiveness of biological treatment for severe chronic rhinosinusitis with nasal polyps
Boris Haxel, Thomas Hummel, Kai Fruth, et al.
Rhinology Journal (2022)
Closed Access | Times Cited: 34
Updates in biologic therapy for chronic rhinosinusitis with nasal polyps and NSAID‐exacerbated respiratory disease
Xinni Xu, Sietze Reitsma, De Yun Wang, et al.
Allergy (2022) Vol. 77, Iss. 12, pp. 3593-3605
Closed Access | Times Cited: 29
Page 1 - Next Page

Scroll to top